BridgeBio Set To Treat Another Unmet Medical Need With ADH1 Phase III Win

 
• By Joseph Haas
  
A blue figure standing in a brown crowd, concept of rare diseases
BridgeBio reported a second Phase III win this week in an untreated rare disease (Shutterstock)

More from Strategy

More from Business